MoneyWorks4Me

Aurobindo Pharma - Quaterly Results

08 Nov 2021 Evaluate
The Sales for the quarter ended September 2021 of Rs. 28831.80 million declined by -36.61% from Rs. 45485.00 millions.The company reported a drastic decline of -75.19% in the quarter ended September 2021 to Rs. 1976.80  millions from Rs. 7969.30 millions  .Operating Profit reported a sharp decline to 4221.00 millions from 12506.90 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 28831.80 45485.00 -36.61 57769.30 79744.90 -27.56 158236.80 133707.70 18.35
Other Income 823.70 431.70 90.80 1263.20 1641.30 -23.04 5898.60 2434.30 142.31
PBIDT 4221.00 12506.90 -66.25 8768.60 23321.50 -62.40 47096.80 29412.90 60.12
Interest 34.40 64.50 -46.67 85.00 168.90 -49.67 286.80 979.10 -70.71
PBDT 4186.60 12442.40 -66.35 8683.60 23152.60 -62.49 46810.00 28433.80 64.63
Depreciation 981.80 1212.50 -19.03 2128.30 2417.10 -11.95 4879.90 4733.30 3.10
PBT 3204.80 11229.90 -71.46 6555.30 20735.50 -68.39 41930.10 23700.50 76.92
TAX 1228.00 3260.60 -62.34 2427.80 5690.90 -57.34 10801.00 4931.70 119.01
Deferred Tax 7.60 51.90 -85.36 -227.00 31.20 -827.56 367.60 8.80 4077.27
PAT 1976.80 7969.30 -75.19 4127.50 15044.60 -72.56 31129.10 18768.80 65.86
Equity 585.90 585.90 0.00 585.90 585.90 0.00 585.90 585.90 0.00
PBIDTM(%) 14.64 27.50 -46.76 15.18 29.25 -48.10 29.76 22.00 35.30
Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..